Abedin, Laga .
HRN: 26-16-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/04/2024
12/11/2024
IV
2.25g
Every 8hours
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes